Development of an efficient endothelial cell specific vector using promoter and 5' untranslated sequences from the human preproendothelin-1 gene.
- Author:
Jung Yoon CHO
1
;
Won Chung LIM
;
Siyoul JANG
;
Young Joo LEE
Author Information
1. Department of Bioscience and Biotechnology, College of Engineering, Sejong University, Seoul 143-747, Korea. yjlee@sejong.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
endothelial cell specific vector;
gene therapy;
naked DNA, preproendothelin-1;
5' untranslated region
- MeSH:
*5' Untranslated Regions;
Animals;
Anoxia/metabolism;
Cattle;
Endothelial Cells/*metabolism;
Endothelin-1/*genetics/metabolism;
Endothelium, Vascular/metabolism;
Gene Transfer Techniques;
*Genetic Vectors;
Human;
*Promoter Regions (Genetics)
- From:Experimental & Molecular Medicine
2003;35(4):269-274
- CountryRepublic of Korea
- Language:English
-
Abstract:
We report here, that a vector constructed based on ppET-1 gene promoter and 5' untranslated region induced a high level of gene expression in endothelial cells and the specificity is even further enhanced under hypoxia-mimic conditions due to a natural hypoxia responsive element within the promoter region. A naked DNA vector that confers endothelial cell specific gene expression as well as efficient levels of gene expression was constructed with an endothelial cell specific naked DNA vector, pETlong, by using the full length promoter of the preproendothelin-1 gene and the entire 5' untranslated region upstream from the start codon. Inclusion of the entire 5' untranslated region in pETlong increased gene expression 2.96 fold as compared with that from pETshort, which contains only the promoter sequences. Reporter gene expression from pETlong was 7.9 fold higher as compared with that from CMV-driven promoter based vector in calf pulmonary endothelial cells. However, in nonendothelial COS cells, luciferase activity from pETlong was only 0.3 fold as compared with that of CMV-based vector. Similar results were observed in other nonendothelial cells. These results demonstrate that the pETlong drives gene expression in endothelial cells with high efficacy and specificity. We have examined hypoxia responsiveness of pETlong as the promoter region of the preproendothelin-1 gene contains hypoxia responsive elements. The activity of the pETlong vector was increased 1.6 fold under hypoxia-mimic conditions using cobalt chloride. The high levels of hypoxia-inducible expression in endothelial cells relative to the low levels of background expression in other cells shows that pETlong could be a useful tool for vascular targeting of vascular disease and cancer gene therapy.
